NUBEQA is a pill

NUBEQA is a prescription medicine that’s approved to treat certain types of advanced prostate cancer.

NUBEQA offers options for a personalized treatment decision

NUBEQA logo in a circle with orange background demonstrating mCSPC
  • Prostate cancer that has spread to
other parts of the body (metastatic) and
responds to ADT*

    NUBEQA is an FDA-approved treatment option with or without chemotherapy

NUBEQA logo in a circle with light blue background demonstrating nmCRPC
  • Prostate cancer that has not spread to
other parts of the body (non-metastatic) and no longer responds to ADT*

    NUBEQA is an FDA-approved treatment option

It is not known if NUBEQA is safe and effective in females and children. 

*ADT refers to a medical or surgical treatment that lowers testosterone.

Chemotherapy=docetaxel.

How NUBEQA works

Graphic of testosterone binding to androgen receptors in prostate cancer cells, causing them to multiply
Graphic of Nubeqa (darolutamide) attaching to androgen receptors in prostate cancer cells, blocking testosterone and delaying cancer cell growth

Video title

NUBEQA is always taken with ADT

For patients with metastatic prostate cancer that responds to ADT:

You and your doctor may consider NUBEQA in combination with ADT alone or ADT + chemotherapy.

Graphic of NUBEQA (darolutamide) in combination with ADT alone or ADT+chemotherapy for patients with metastatic prostate cancer that responds to ADT

For patients with non-metastatic prostate cancer that does not respond to ADT:

You and your doctor may consider
NUBEQA in combination with ADT.

Graphic of NUBEQA (darolutamide) in combination with ADT for patients with non-metastatic prostate cancer that does not responds to ADT

If your prostate cancer has spread and responds to ADT, you and your doctor will decide if including chemotherapy is right for you.

Learn about
NUBEQA results

For metastatic prostate cancer that responds to ADT:

See the clinical studies

For non-metastatic prostate cancer that does not respond to ADT:

See the clinical study